Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 8 results.
User Information
Export Records
  1. 1.   Twice-weekly pegylated interferon-alpha-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy
  2. Murphy, A. A.; Herrmann, E.; Osinusi, A. O.; Wu, L.; Sachau, W.; Lempicki, R. A.; Yang, J.; Chung, T. L.; Wood, B. J.; Haagmans, B. L.; Kottilil, S.; Polis, M. A.
  3. Aids. 2011, Jun; 25(9): 1179-1187.
  1. 2.   Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa-2a in HIV-1-Monoinfected Participants: A Phase II Clinical Trial
  2. Asmuth, D. M.; Murphy, R. L.; Rosenkranz, S. L.; Lertora, J. J. L.; Kottilil, S.; Cramer, Y.; Chan, E. S.; Schooley, R. T.; Rinaldo, C. R.; Thielman, N.; Li, X. D.; Wahl, S. M.; Shore, J.; Janik, J.; Lempicki, R. A.; Simpson, Y.; Pollard, R. B.; Tea, A. C. T. G. A.
  3. Journal of Infectious Diseases. 2010, Jun 1; 201(11): 1686-1696.
  1. 3.   Interleukin-27, an Anti-HIV-1 Cytokine, Inhibits Replication of Hepatitis C Virus
  2. Frank, A. C.; Zhang, X. Z.; Katsounas, A.; Bharucha, J. P.; Kottilil, S.; Imamichi, T.
  3. Journal of Interferon and Cytokine Research. 2010, Jun; 30(6): 427-431.
  1. 4.   Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4(+) T-Cell Counts
  2. Avidan, N. U.; Goldstein, D.; Rozenberg, L.; McLaughlin, M.; Ferenci, P.; Masur, H.; Buti, M.; Fauci, A. S.; Polis, M. A.; Kottilil, S.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2009 52(4): 452-458.
  1. 5.   Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
  2. Thomas, D. L.; Thio, C. L.; Martin, M. P.; Qi, Y.; Ge, D.; O'hUigin, C.; Kidd, J.; Kidd, K.; Khakoo, S. I.; Alexander, G.; Goedert, J. J.; Kirk, G. D.; Donfield, S. M.; Rosen, H. R.; Tobler, L. H.; Busch, M. P.; McHutchison, J. G.; Goldstein, D. B.
  3. Nature. 2009 461(7265): 798-U52.
  1. 6.   Variants in Interferon-Alpha Pathway Genes and Response to Pegylated Interferon-Alpha2a Plus Ribavirin for Treatment of Chronic Hepatitis C Virus Infection in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
  2. Welzel, T. M.; Morgan, T. R.; Bonkovsky, H. L.; Naishadham, D.; Pfeiffer, R. M.; Wright, E. C.; Hutchinson, A. A.; Crenshaw, A. T.; Bashirova, A.; Carrington, M.; Dotrang, M.; Sterling, R. K.; Lindsay, K. L.; Fontana, R. J.; Lee, W. M.
  3. Hepatology. 2009 49(6): 1847-1858.
  1. 7.   Hepatic histologic response (HR) to combination therapy among HCV/HIV-coinfected individuals: Interferon induces HR independent of sustained virologic response (SVR)
  2. Wu, L.; Kottilil, S.; Lempicki, R.; Yang, J.; McLaughlin, M.; Hu, Z. H.; Koratich, C.; Reitano, K. N.; Rehm, C. A.; Masur, H.; Wood, B.; Kleiner, D. E.; Polis, M. A.
  3. Aids Research and Human Retroviruses. 2006, Nov; 22(11): 1091-1098.
  1. 8.   Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: Class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons
  2. Lempicki, R. A.; Polis, M. A.; Yang, J.; McLaughlin, M.; Koratich, C.; Huang, D. W.; Fullmer, B.; Wu, L.; Rehm, C. A.; Masur, H.; Lane, H. C.; Sherman, K. E.; Fauci, A. S.; Kottilil, S.
  3. Journal of Infectious Diseases. 2006, Apr; 193(8): 1172-1177.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel